CRISPR Therapeutics CRSP 深 滬
等待開盤 10-08 09:30:00 美东时间
52.35
-1.650
-3.06%
華盛通- 最 高54.59
- 今 開53.00
- 成交量 167.99万股
- 最 低 52.27
- 昨 收 54.00
- 總市值 50.62亿
- 52周最高 75.06
- 市盈率 靜 --
- 換手率 1.74%
- 52周最低 44.12
- 委 比 -66.67%
- 總股本 9669.27万
- 歷史最高 220.20
- 量 比 1.09
- 振 幅 4.30%
- 歷史最低 13.50
- 每 手 1
- 風險率 5.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
CRISPR Therapeutics announced that it will present Phase 1 clinical data for its investigational CRISPR/Cas9 gene-edited allogeneic CAR T cell therapy, zugocabtagene geleucel (zugo-cel), targeting CD19 for autoimmune diseases, at the American College of Rheumatology (ACR) Convergence 2026. The poster presentation, titled "Safety and Efficacy of Anti-CD19 Allogeneic Chimeric Antigen Receptor (CAR) T Cell Therapy Zugocabtagene Geleucel (zugo-cel) i...
10-02 14:15
Insider trades: Nvidia, Oracle, Salesforce among notable names
This week, insider transactions were seen across major technology companies, including Nvidia (NVDA), Oracle (ORCL), and Salesforce (CRM). The following transactions took place between September 21 an...
09-26 23:03
Anthropic IPO前亮科研牌：Claude“自主发现”类CRISPR系统，基因编辑板块遭遇“AI替代焦虑”
周三，美股基因编辑公司股价走低。此前，Anthropic宣布，其AI模型Claude“自主发现”了一种类似于基因编辑工具CRISPR的新型酶系统。 个股方面，...
09-24 07:21
Gene editing stocks fall after Anthropic’s CRISPR-like discovery
Gene editing companies traded lower on Wednesday after Anthropic (ANTHRO) said that its AI model Claude has “autonomously discovered” a new enzyme system similar to the gene-editing tool CRISPR. Notab...
09-24 02:33
CRISPR Therapeutics shares are trading lower after reports that Anthropic's Biolab has discovered a new enzyme system that resembles the Crispr gene editing tool.
CRISPR Therapeutics shares are trading lower after reports that Anthropic's Biolab has discovered a new enzyme system that resembles the Crispr gene editing tool.
09-24 02:10
CRISPR Therapeutics set to snap six-session losing streak
CRISPR Therapeutics (CRSP) is set to snap six straight sessions of losses, as the stock was up more than 3% at $53.32 on Monday. The company lost 8.5% over the past six sessions. The stock closed 1.03...
09-15 01:06
Cathie Wood's Ark weekly recap: buys Meta, gene-editing stocks while cutting Alphabet
Cathie Wood’s Ark Invest stepped up bets on biotechnology and AI during the last week, with Meta Platforms (META) and a group of gene-editing companies among its biggest purchases, while cutting expos...
09-14 19:10
Cathie Wood Says AI Revolution Could Supercharge Global Growth — TSLA, COIN and CRSP Stocks Are Among Her Top Bets
ARK Invest CEO Cathie Wood says the ongoing technological shift mirrors the Industrial Revolution. Outlining her macroeconomic outlook, she said, “rapid real growth is where we’re going,” expecting the global real GDP growth rate to at least double in the coming years. The Five Innovation Platforms ...
09-07 14:46
美股大行评级 | Affirm、GitLab获多家大行上调目标价；Attovia获大摩、花旗首予买入评级
今日重点评级关注：杰富瑞：维持拜玛林制药"买入"评级，目标价从104美元升至105美元；RBC Capital：维持Shift4 Payments"跑赢大市"评级，目标价从63美元升至67美元
09-01 08:37
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
